Aduhelm is also a potentially fatal drug. Even ignoring cost, evidence that the tiny amount of good that it might do exceeds the clearly evident harm it can do

Aduhelm is also a potentially fatal drug. Even ignoring cost, evidence that the tiny amount of good that it might do exceeds the clearly evident harm it can do is, to put it mildly, lacking. https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-probes-death-aduhelm-user-after-brain-swelling-2021-11-09/ https://www.reuters.com/business/healthcare-pharmaceuticals/... Keep in mind that, while only one patient was known to have died at the time the article was written, not a whole lot of patients had been treated.